Based on the finding that GR signalling did not depend on the presence of the ligand, we screened genes that exhibited a significant positive and negative correlation with NR3C1 in breast cancer tissue samples (10,455 samples analyzed by 57 microarray studies and 4421 samples analyzed by three RNAseq studies). Here, NR3C1 is linked to breast carcinoma.